For information on this past event please contact Meetings Management

Provisional Conference Program

Friday 17th November 2006

PLENARY SESSION 9:
INFLUENZA VACCINES
Moderator: Jim Robertson (NIBSC, Potters Bar, UK)

09.00-09.30
‘Reverse vaccinology for influenza vaccines’
Jim Robertson (NIBSC, Potters Bar, UK)

09.30-10.00
‘New developments in pandemic influenza vaccines’
Rob Lambkin-Williams and John Oxford (Retroscreen Virology Ltd, London, UK)

10.00-10.30
‘Recombinant epitope-based vaccine against influenza’
Tammy Ben-Yedidia and Ruth Arnon (BiondVax Pharmaceuticals/The Weizmann Institute, Rehovot, Israel)

10.30-11.00
Coffee Break & Posters

PLENARY SESSION 10:
MALARIA VACCINES
Moderator: Adrian Hill (University of Oxford)

11.00-11.30
‘Malaria vaccine development – an update and overview on progress’
Adrian Hill (University of Oxford, UK)

11.30-12.00
‘Development of AHA-1-based malaria vaccines’
Ed Remarque and Alan W. Thomas (Biomedical Primate Research Centre, Rijswijk, The Netherlands)

12.00-12.20
‘Pre-clinical studies in malaria vaccine development: From epitope prediction to peptide immunization and parasite challenge’
Celia Aurora T. Torres-Villanueva, K.E.C. Fang and G.F.A. Cuesta (University of the Philippines, Quezon City, Philippines)

12.20-12.40
‘Genetically attenuated P36p-deficient Pasmodium berghei sporozites confer long-lasting protection and partial cross-species immunity’
Bruno Douradinha (University of Lisbon, Portugal)

12.40-14.00
Lunch & Poster Breakdown

CLOSING PLENARY SESSION
Moderator: Alex von Gabain (Intercell AG, Vienna, Austria)

14.00-15.00
Summary Panel Discussion from GPADV 2006 led by
Alex von Gabain (Intercell AG, Vienna, Austria)

Panel Discussion Members
To be confirmed

Conference Close & Departure